Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS, page-136

What a great announcement! I see as usual most are focusing on the share price but let's look a little at the science. Good to see viral load numbers reduced but for me, the reduction in cytokines was a standout since this is usually the reason for death in a covid infected patient. The cytokine storm has no real treatment other than to pump the patient full of steroids to suppress the immune response. This point has never made sense to me. Biotron may have stumbled on an alternative treatment. I'm raising my price target to $3 per share.

I'd like to hear from some brainiacs with better qualifications than mine. Is this significant?

Please note, my qualifications were obtained from submitting a voucher on the back of a Weetabix packet.

On a side note, I feel quite bad about voting against many resolutions at the recent meeting. MM can you forgive me?